597 related articles for article (PubMed ID: 18639389)
21. Nipple fluid basic fibroblast growth factor in patients with breast cancer.
Sartippour MR; Zhang L; Lu M; Wang HJ; Brooks MN
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2995-8. PubMed ID: 16365024
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy weight gain and premenopausal breast cancer risk.
Hilakivi-Clarke L; Luoto R; Huttunen T; Koskenvuo M
J Reprod Med; 2005 Nov; 50(11):811-6. PubMed ID: 16419626
[TBL] [Abstract][Full Text] [Related]
23. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status.
Maehle BO; Tretli S; Thorsen T
APMIS; 2004 Jun; 112(6):349-57. PubMed ID: 15511272
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins.
Gann PH; Geiger AS; Helenowski IB; Vonesh EF; Chatterton RT
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):39-44. PubMed ID: 16434584
[TBL] [Abstract][Full Text] [Related]
25. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
[TBL] [Abstract][Full Text] [Related]
26. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
Vrieling A; Buck K; Kaaks R; Chang-Claude J
Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen value as a marker in breast cancer.
Narita D; Cimpean AM; Anghel A; Raica M
Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
[TBL] [Abstract][Full Text] [Related]
28. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
[TBL] [Abstract][Full Text] [Related]
29. Body mass and mortality after breast cancer diagnosis.
Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Marchbanks PA
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2009-14. PubMed ID: 16103453
[TBL] [Abstract][Full Text] [Related]
30. Association of serum adiponectin levels with breast cancer risk.
Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
[TBL] [Abstract][Full Text] [Related]
31. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
[TBL] [Abstract][Full Text] [Related]
32. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
[TBL] [Abstract][Full Text] [Related]
33. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
34. Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer.
Mannello F; Tonti GA; Medda V; Pederzoli A; Sauter ER
Cancer Sci; 2008 Nov; 99(11):2160-9. PubMed ID: 18811693
[TBL] [Abstract][Full Text] [Related]
35. Impact of body mass index on cancer development.
Yumuk PF; Dane F; Yumuk VD; Yazici D; Ege B; Bekiroglu N; Toprak A; Iyikesici S; Basaran G; Turhal NS
J BUON; 2008; 13(1):55-9. PubMed ID: 18404787
[TBL] [Abstract][Full Text] [Related]
36. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
37. Body mass, depressive symptoms and menopausal status: an examination of the "Jolly Fat" hypothesis.
Jasienska G; Ziomkiewicz A; Górkiewicz M; Pajak A
Womens Health Issues; 2005; 15(3):145-51. PubMed ID: 15894200
[TBL] [Abstract][Full Text] [Related]
38. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
[TBL] [Abstract][Full Text] [Related]
39. Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women.
Pinheiro RL; Sarian LO; Pinto-Neto AM; Morais S; Costa-Paiva L
Breast; 2009 Feb; 18(1):8-12. PubMed ID: 19041243
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen (PSA) in women.
Yu H; Berkel H
J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
